May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Stabilized-Angiostatin Gene Transfer: Inhibition of Metastasis Development in an Eye-tumor Transgenic Mouse Model
Author Affiliations & Notes
  • E. Frau
    Ophthalmology, Bicetre Hopital, Bicêtre, France
  • C. Bouquet
    Umr8121, Institut Gustave Roussy, Villejuif, France
  • P. Opolon
    Umr8121, Institut Gustave Roussy, Villejuif, France
  • M. Labetoulle
    Umr8121, Institut Gustave Roussy, Villejuif, France
  • M. Abitbol
    Certo, Hopital Necker, Paris, France
  • M. Perricaudet
    Umr 8121, Institut Gustave Roussy, Villejuif, France
  • Footnotes
    Commercial Relationships  E. Frau, None; C. Bouquet, None; P. Opolon, None; M. Labetoulle, None; M. Abitbol, None; M. Perricaudet, None.
  • Footnotes
    Support  Santen Pharmaceutical
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4983. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Frau, C. Bouquet, P. Opolon, M. Labetoulle, M. Abitbol, M. Perricaudet; Stabilized-Angiostatin Gene Transfer: Inhibition of Metastasis Development in an Eye-tumor Transgenic Mouse Model . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4983.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: : Angiostatin can inhibit growth of different types of tumors . In order to increase the half-life of this anti-angiogenic factor in vivo, we have fused it to HSA (human serum albumin) and studied the biological properties of the chimeric molecule Methods: A chimeric gene coding for a conjugate between angiostatin and HSA (K1-3 – HSA) was inserted under the control of the early promoter of CMV within an E1/E3-deleted recombinant adenovirus (AdK3-HSA). AdCO1 were used as controls. Activity of the K1-3 - HSA conjugate: human endothelial HMEC-1 cells were infected with the virus to perform an in vitro proliferation assay.Nude mice were injected intravenously with 5 109 pfu of AdCO1, AdK3 or AdK3-HSA. Expression levels of K3 and K3-HSA were monitored by ELISA over 91 days after virus injection.MDA-MB-231 human breast carcinoma were grown on the dorsa of female nude mice. When tumor volumes reached 30 mm3, mice were injected intravenously with 5. 109 pfu of AdK3-HSA, AdK3, or AdCO1. The anti-metastatic effect of high serum K3-HSA levels was further characterized in a transgenic mouse model (TRP1) which spontaneously develop tumors of the retinal pigment epithelium with brain metastases .A dose of 109 pfu of AdK3-HSA, AdK3, or AdCO1 was injected into the temporal vein of 3 day-old TRP-1 male mice, a second i.v. injection was administered 12 days later.Blood was collected weekly until the animals were sacrified on day 62 after birth. The quantity of K3-HSA was determined by sandwich ELISA. We have evaluate the survival of AdK3-HSA injected mice. Results: Systemic injection of AdK3-HSA in immunodeficient mice led to robust and long-lasting expression of the chimeric antagonist as compared to its unfused counterpart, together with a more pronounced effect on the growth of MDA-MB-231 grafted tumors (79% inhibition with AdK3-HSA versus 44% with AdK3), Antitumoral effects associated with systemic injection of AdK3 virus in TRP-1 transgenic mice: Two months after virus injections, only 46% of AdK3-HSA treated animals developed metastases in the brain ( 0.95 mm3 ± 1.87 mm3) whereas 94% of the AdCO1-injected group displayed numerous and larger metastases ( 4.33 mm3 ± 6.6 mm3) These antitumoral effects were associated with an extended life span in the AdK3-HSA group (4 weeks over AdCO1-injected animals) Conclusions: Our data demonstrate that the use of HSA-stabilized anti-angiogenic factors delivered by gene transfer can block primary tumor growth and can prevent metastasis.

Keywords: adenovirus • gene transfer/gene therapy • oncology 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.